Location History:
- Dollard des Ormeaux, CA (1976 - 1983)
- Beaconsfield, CA (1983)
- Princeton, NJ (US) (1988 - 1997)
Company Filing History:
Years Active: 1976-1997
Title: Innovations in Immunosuppression: The Contributions of Surendra N. Sehgal
Introduction
Surendra N. Sehgal, a prominent inventor based in Princeton, NJ, has made significant contributions to the field of immunosuppression, holding an impressive portfolio of 19 patents. His work focuses on innovative techniques that have the potential to transform treatments for various diseases.
Latest Patents
One of Surendra N. Sehgal’s latest patents involves an innovative technique for immunosuppression utilizing rapamycin. This invention describes a method for treating a mammal by first removing blood from the patient. The formed blood elements are then treated with rapamycin, which binds rapidly and reversibly to erythrocytes. The treated blood cells are returned to the patient's circulatory system, offering a novel approach to treating diseases, syndromes, conditions, or immune responses that respond to rapamycin. As an alternative, blood may also be sourced from a hematologically compatible donor mammal for treatment.
Career Highlights
Throughout his career, Surendra N. Sehgal has worked with reputable organizations, including American Home Products Corporation and Ayerst, McKenna & Harrison, Inc. His experiences in these companies have contributed to his expertise and development in innovative pharmaceutical techniques.
Collaborations
Surendra has collaborated with notable professionals in the field, including Claude Vezina and Jay J. Armstrong. These collaborations have played a vital role in the advancement of his research and patents, showcasing the importance of teamwork in driving innovation.
Conclusion
Surendra N. Sehgal has established himself as an exemplary inventor in the realm of immunosuppression. With 19 patents to his name, his innovative techniques promise to affect medical treatments positively. The future of his work holds the potential to impact the medical industry significantly, underscoring the importance of continued research and innovation in health care.